Report Detail
Global General Anesthesia Drugs Market Growth 2019-2024
- RnM2881567 |
- 05 February, 2019 |
- Global |
- 165 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.
General Anesthesia Drugs can be divided into two categories, Intravenous Anesthetics, accounting for 69.62% and Inhalational Anesthetics, accounting for 30.38%. Intravenous Anesthetics widely used drugs are: Propofol, Etomidate, Midazolam, Barbiturates (such as thiopental), and so on. Desflurane, Isoflurane and Sevoflurane are the most widely used Inhalational Anesthetics. Propofol hold the largest market share of General Anesthesia Drugs with 33.83% market share. Sevoflurane market share is over 21.17%, being the second largest market share of General Anesthesia Drugs.
Europe is the largest supplier and consumption market of General Anesthesia Drugs, with a production market share of nearly 38% and sales market share nearly 32%. The second place is USA, following Europe with the production market share of 20% and the sales market share over 28%. Asia is another important market of General Anesthesia Drugs, enjoying 24% production market share and 25% sales market share.
According to this study, over the next five years the General Anesthesia Drugs market will register a 3.9% CAGR in terms of revenue, the global market size will reach US$ 8170 million by 2024, from US$ 6500 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in General Anesthesia Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of General Anesthesia Drugs market by product type, application, key manufacturers and key regions and countries.
This study considers the General Anesthesia Drugs value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Propofol
Etomidate
Midazolam
Sevoflurane
Isoflurane
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Intravenous Anesthetics
Inhalational Anesthetics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global General Anesthesia Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of General Anesthesia Drugs market by identifying its various subsegments.
Focuses on the key global General Anesthesia Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the General Anesthesia Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of General Anesthesia Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global General Anesthesia Drugs Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global General Anesthesia Drugs Consumption 2014-2024
- 2.1.2 General Anesthesia Drugs Consumption CAGR by Region
- 2.2 General Anesthesia Drugs Segment by Type
- 2.2.1 Propofol
- 2.2.2 Etomidate
- 2.2.3 Midazolam
- 2.2.4 Sevoflurane
- 2.2.5 Isoflurane
- 2.2.6 Others
- 2.3 General Anesthesia Drugs Consumption by Type
- 2.3.1 Global General Anesthesia Drugs Consumption Market Share by Type (2014-2019)
- 2.3.2 Global General Anesthesia Drugs Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global General Anesthesia Drugs Sale Price by Type (2014-2019)
- 2.4 General Anesthesia Drugs Segment by Application
- 2.4.1 Intravenous Anesthetics
- 2.4.2 Inhalational Anesthetics
- 2.5 General Anesthesia Drugs Consumption by Application
- 2.5.1 Global General Anesthesia Drugs Consumption Market Share by Application (2014-2019)
- 2.5.2 Global General Anesthesia Drugs Value and Market Share by Application (2014-2019)
- 2.5.3 Global General Anesthesia Drugs Sale Price by Application (2014-2019)
3 Global General Anesthesia Drugs by Players
- 3.1 Global General Anesthesia Drugs Sales Market Share by Players
- 3.1.1 Global General Anesthesia Drugs Sales by Players (2017-2019)
- 3.1.2 Global General Anesthesia Drugs Sales Market Share by Players (2017-2019)
- 3.2 Global General Anesthesia Drugs Revenue Market Share by Players
- 3.2.1 Global General Anesthesia Drugs Revenue by Players (2017-2019)
- 3.2.2 Global General Anesthesia Drugs Revenue Market Share by Players (2017-2019)
- 3.3 Global General Anesthesia Drugs Sale Price by Players
- 3.4 Global General Anesthesia Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global General Anesthesia Drugs Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players General Anesthesia Drugs Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 General Anesthesia Drugs by Regions
- 4.1 General Anesthesia Drugs by Regions
- 4.1.1 Global General Anesthesia Drugs Consumption by Regions
- 4.1.2 Global General Anesthesia Drugs Value by Regions
- 4.2 Americas General Anesthesia Drugs Consumption Growth
- 4.3 APAC General Anesthesia Drugs Consumption Growth
- 4.4 Europe General Anesthesia Drugs Consumption Growth
- 4.5 Middle East & Africa General Anesthesia Drugs Consumption Growth
5 Americas
- 5.1 Americas General Anesthesia Drugs Consumption by Countries
- 5.1.1 Americas General Anesthesia Drugs Consumption by Countries (2014-2019)
- 5.1.2 Americas General Anesthesia Drugs Value by Countries (2014-2019)
- 5.2 Americas General Anesthesia Drugs Consumption by Type
- 5.3 Americas General Anesthesia Drugs Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC General Anesthesia Drugs Consumption by Countries
- 6.1.1 APAC General Anesthesia Drugs Consumption by Countries (2014-2019)
- 6.1.2 APAC General Anesthesia Drugs Value by Countries (2014-2019)
- 6.2 APAC General Anesthesia Drugs Consumption by Type
- 6.3 APAC General Anesthesia Drugs Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe General Anesthesia Drugs by Countries
- 7.1.1 Europe General Anesthesia Drugs Consumption by Countries (2014-2019)
- 7.1.2 Europe General Anesthesia Drugs Value by Countries (2014-2019)
- 7.2 Europe General Anesthesia Drugs Consumption by Type
- 7.3 Europe General Anesthesia Drugs Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa General Anesthesia Drugs by Countries
- 8.1.1 Middle East & Africa General Anesthesia Drugs Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa General Anesthesia Drugs Value by Countries (2014-2019)
- 8.2 Middle East & Africa General Anesthesia Drugs Consumption by Type
- 8.3 Middle East & Africa General Anesthesia Drugs Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 General Anesthesia Drugs Distributors
- 10.3 General Anesthesia Drugs Customer
11 Global General Anesthesia Drugs Market Forecast
- 11.1 Global General Anesthesia Drugs Consumption Forecast (2019-2024)
- 11.2 Global General Anesthesia Drugs Forecast by Regions
- 11.2.1 Global General Anesthesia Drugs Forecast by Regions (2019-2024)
- 11.2.2 Global General Anesthesia Drugs Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global General Anesthesia Drugs Forecast by Type
- 11.8 Global General Anesthesia Drugs Forecast by Application
12 Key Players Analysis
- 12.1 Astrazeneca
- 12.1.1 Company Details
- 12.1.2 General Anesthesia Drugs Product Offered
- 12.1.3 Astrazeneca General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Astrazeneca News
- 12.2 Fresenius-Kabi
- 12.2.1 Company Details
- 12.2.2 General Anesthesia Drugs Product Offered
- 12.2.3 Fresenius-Kabi General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Fresenius-Kabi News
- 12.3 AbbVie
- 12.3.1 Company Details
- 12.3.2 General Anesthesia Drugs Product Offered
- 12.3.3 AbbVie General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 AbbVie News
- 12.4 Baxter Healthcare
- 12.4.1 Company Details
- 12.4.2 General Anesthesia Drugs Product Offered
- 12.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Baxter Healthcare News
- 12.5 B.Braun
- 12.5.1 Company Details
- 12.5.2 General Anesthesia Drugs Product Offered
- 12.5.3 B.Braun General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 B.Braun News
- 12.6 Maruishi
- 12.6.1 Company Details
- 12.6.2 General Anesthesia Drugs Product Offered
- 12.6.3 Maruishi General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Maruishi News
- 12.7 Piramal
- 12.7.1 Company Details
- 12.7.2 General Anesthesia Drugs Product Offered
- 12.7.3 Piramal General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Piramal News
- 12.8 Hikma Pharmaceuticals
- 12.8.1 Company Details
- 12.8.2 General Anesthesia Drugs Product Offered
- 12.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Hikma Pharmaceuticals News
- 12.9 Mylan
- 12.9.1 Company Details
- 12.9.2 General Anesthesia Drugs Product Offered
- 12.9.3 Mylan General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Mylan News
- 12.10 Nhwa
- 12.10.1 Company Details
- 12.10.2 General Anesthesia Drugs Product Offered
- 12.10.3 Nhwa General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Nhwa News
- 12.11 Hengrui
- 12.12 Lunan
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on General Anesthesia Drugs . Industry analysis & Market Report on General Anesthesia Drugs is a syndicated market report, published as Global General Anesthesia Drugs Market Growth 2019-2024. It is complete Research Study and Industry Analysis of General Anesthesia Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
